These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3595040)

  • 1. Proposed guidelines for screening of metabolic and endocrine diseases of dependent neonates of the U.S. Armed Forces. Derived from a survey of state guidelines for neonatal screening of metabolic diseases.
    Tiwary CM
    Clin Pediatr (Phila); 1987 Jul; 26(7):349-54. PubMed ID: 3595040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal screening for metabolic and endocrine diseases.
    Tiwary CM
    Nurse Pract; 1987 Sep; 12(9):28-35, 38, 41. PubMed ID: 3118277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].
    Bozkowa K; Cabalska B; Radomyska B; Ołtarzewski M; Lenartowska I
    Med Wieku Rozwoj; 1999; 3(4):529-59. PubMed ID: 10910678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for metabolic and endocrine disorders.
    Larsson A
    Ups J Med Sci Suppl; 1987; 44():231-6. PubMed ID: 3481902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of a nation-wide neonatal metabolic screening program in Japan. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan.
    Tada K; Tateda H; Arashima S; Sakai K; Kitagawa T; Aoki K; Suwa S; Kawamura M; Oura T; Takesada M
    Eur J Pediatr; 1984 Aug; 142(3):204-7. PubMed ID: 6468444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of congenital hypothyroidism, phenylketonuria, galactosemia, homocystinuria, and maple syrup urine disease in moderate to severe mentally retarded Chinese children.
    Hsiao KJ; Chen CH; Liu TT; Wu SJ; Plettner C; Clemens P
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):18-22. PubMed ID: 2787833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
    Widhalm K
    Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow-up of patients with inborn errors of metabolism detected by the newborn screening program in Japan.
    Aoki K
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():19-23. PubMed ID: 15906687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West Germany.
    Mathias D; Bickel H
    Eur J Pediatr; 1986 Sep; 145(4):310-2. PubMed ID: 3770001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening in Japan.
    Aoki K
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():80. PubMed ID: 15906702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for congenital disorders.
    Gudat JC; Maclaren NK
    J Fla Med Assoc; 1980 Feb; 67(2):137-42. PubMed ID: 7359105
    [No Abstract]   [Full Text] [Related]  

  • 13. Health economic analysis of the Swedish neonatal metabolic screening programme. A method of optimizing routines.
    Alm J; Larsson A; Rosenqvist U
    Med Decis Making; 1982; 2(1):33-45. PubMed ID: 6820461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of the Manitoba Perinatal Screening Program, 1965-85.
    Fox JG
    CMAJ; 1987 Nov; 137(10):883-8. PubMed ID: 3676929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for inborn errors of metabolism in Japan. A history of the development of newborn screening.
    Kitagawa T
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():8-25. PubMed ID: 23330242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive cost-utility analysis of newborn screening strategies.
    Carroll AE; Downs SM
    Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic diseases--screening of newborn infants].
    Søvik O
    Tidsskr Nor Laegeforen; 1995 Feb; 115(5):582-3. PubMed ID: 7900108
    [No Abstract]   [Full Text] [Related]  

  • 19. State screening for metabolic disorders in newborns.
    Stevens MB; Rigilano JC; Wilson CC
    Am Fam Physician; 1988 Apr; 37(4):223-8. PubMed ID: 3358346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal screening in Denmark. Status and future perspectives].
    Simonsen H; Brandt NJ; Nørgaard-Pedersen B
    Ugeskr Laeger; 1998 Sep; 160(40):5777-82. PubMed ID: 9782755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.